Characterization of enhancer function from genome-wide analyses.
There has been a recent surge in the use of genome-wide methodologies to identify and annotate the transcriptional regulatory elements in the human genome. Here we review some of these methodologies and the conceptual insights about transcription regulation that have been gained from the use of genome-wide studies. It has become clear that the binding of transcription factors is itself a highly regulated process, and binding does not always appear to have functional consequences. Numerous properties have now been associated with regulatory elements that may be useful in their identification. Several aspects of enhancer function have been shown to be more widespread than was previously appreciated, including the highly combinatorial nature of transcription factor binding, the postinitiation regulation of many target genes, and the binding of enhancers at early stages to maintain their competence during development. Going forward, the integration of multiple genome-wide data sets should become a standard approach to elucidate higher-order regulatory interactions.
Howard Hughes Medical Institute and Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. glenn.a.maston@athenadiagnostics.com
Glenn A
GA
Maston
Stephen G
SG
Landt
Michael
M
Snyder
Michael R
MR
Green
D000818:Animals; D001483:Base Sequence; D047369:Chromatin Immunoprecipitation; D017124:Conserved Sequence; D004742:Enhancer Elements, Genetic; D005786:Gene Expression Regulation; D015894:Genome, Human; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D011485:Protein Binding; D017422:Sequence Analysis, DNA; D014157:Transcription Factors / Q000378:metabolism / Q000502:physiology*
D014157:Transcription Factors